The Instructions for Use (IFU) for: Carotid Patch and Gelsoft Patch vascular patches. FSN s...

FDA Device Recall #Z-2543-2021 — Class II — July 8, 2021

Recall Summary

Recall Number Z-2543-2021
Classification Class II — Moderate risk
Date Initiated July 8, 2021
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Vascutek, Ltd.
Location Inchinnan, N/A
Product Type Devices
Quantity 159 total vascular grafts and patches

Product Description

The Instructions for Use (IFU) for: Carotid Patch and Gelsoft Patch vascular patches. FSN says Tapered Carotid Patch 920875t

Reason for Recall

The devices contained the IFU for distribution to ROW (rest of world) consignees rather than U.S. consignees.

Distribution Pattern

Distribution was made to PR and Guam.

Lot / Code Information

To be reported.

Other Recalls from Vascutek, Ltd.

Recall # Classification Product Date
Z-1492-2026 Class II Gelsoft Plus, REF: 635024PE, 631514PE, 631222PE... Dec 18, 2025
Z-2542-2021 Class II The Instructions for Use (IFU) for: Gelsoft Pl... Jul 8, 2021
Z-1912-2015 Class II Gelseal Straight Diameter 8mm Length 15cm. V... May 15, 2015
Z-1913-2015 Class II Gelseal Straight Diameter 8mm Length 30cm. V... May 15, 2015
Z-2266-2014 Class II Gelweave (TM) Vascular Prostheses Manufactured... Jul 15, 2014

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.